Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Ei, Schwartz"'
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::84e423325ddcbbd675f7262e7e584c99
https://pubmed.ncbi.nlm.nih.gov/1841370
https://pubmed.ncbi.nlm.nih.gov/1841370
Autor:
Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Pusztai L; Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT., Rugo HS; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA., Amiri-Kordestani L; US Food and Drug Administration, Silver Spring, MD., Basho RK; The Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, CA., Best AF; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD., Boileau JF; Department of Surgery, McGill University, Montreal, Quebec, Canada., Denkert C; Institute of Pathology, Philipps University Marburg and University Hospital Marburg (UKGM), Marburg, Germany., Foster JC; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD., Harbeck N; The Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany., Jacene HA; Department of Radiology, Brigham and Women's Hospital, Boston, MA., King TA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA., Mason G; The Inflammatory Breast Cancer Research Foundation, Broadway, VA., O'Sullivan CC; Department of Oncology, Mayo Clinic, Rochester, MN., Prowell TM; US Food and Drug Administration, Silver Spring, MD.; Women's Malignancies Disease Group, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD., Richardson AL; Department of Pathology, John Hopkins Medicine, Baltimore, MD., Sepulveda KA; Department of Radiology, Baylor College of Medicine, Houston, TX., Smith ML; Research Advocacy Network, Plano, TX., Tjoe JA; Division of Breast Surgery, Department of Surgery, Novant Health, Greensboro, NC., Turashvili G; Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, GA., Woodward WA; Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Butler LP; The Emmes Corporation, Rockville, MD., Schwartz EI; Coordinating Center for Clinical Trials, National Cancer Institute, Rockville, MD., Korde LA; Cancer Therapy and Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Sep 20; Vol. 41 (27), pp. 4433-4442. Date of Electronic Publication: 2023 Jul 11.
Autor:
Kumar S; Hematologic Malignancies, Mayo Clinic College of Medicine and Science, Rochester, USA., Baizer L; Division of Lung Diseases, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. baizerl@mail.nih.gov., Callander NS; Myeloma Clinical Program, University of Wisconsin Carbone Cancer Center, Madison, USA., Giralt SA; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Madison, USA., Hillengass J; Oncology and Internal Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, USA., Freidlin B; Biometric Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Hoering A; Cancer Research and Biostatistics and University of Washington School of Public Health, Seattle, USA., Richardson PG; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, USA., Schwartz EI; Coordinating Center for Clinical Trials, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Reiman A; University of New Brunswick, Department of Medicine, Dalhousie University Department of Oncology, Saint John Regional Hospital, Fredericton, Canada., Lentzsch S; Multiple Myeloma and Amyloidosis Service, Department of Medicine, Columbia University Medical Center, New York, USA., McCarthy PL; Department of Medicine, Oncology and Internal Medicine, Transplant & Cellular Therapy Center, Roswell Park Comprehensive Cancer Center, Buffalo, USA., Jagannath S; Division of Hematology and Medical Oncology, Mount Sinai School of Medicine, Center of Excellence for Multiple Myeloma, New York, USA., Yee AJ; Department of Medicine, Harvard Medical School, Multiple Myeloma Program, Medical Oncology, Massachusetts General Hospital, Boston, USA., Little RF; Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Raje NS; Department of Medicine, Harvard Medical School, Multiple Myeloma Program, Medical Oncology, Massachusetts General Hospital, Boston, USA.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2022 Jun 29; Vol. 12 (6), pp. 98. Date of Electronic Publication: 2022 Jun 29.
Autor:
Gunter KE; University of Chicago., Peek ME; University of Chicago., Tanumihardjo JP; University of Chicago., Carbrey E; Minneapolis Healthy Living Initiative, Minneapolis Health Department., Crespo RD; Marshall University School of Medicine., Johnson TW; Providence Health & Services., Rueda-Yamashita B; Diabetes Program, Alameda County Public Health Department., Schwartz EI; Institute for Urban Care, Capital Health., Sol C; La Clínica del Pueblo., Wilkinson CM; St. Mary's Health and Clearwater Valley Health., Wilson JO; UPMC Western Maryland., Loehmer E; University of Chicago., Chin MH; University of Chicago.
Publikováno v:
The Milbank quarterly [Milbank Q] 2021 Dec; Vol. 99 (4), pp. 928-973. Date of Electronic Publication: 2021 Sep 01.
Autor:
Schwartz EI; Panacea Pharmaceuticals, Inc., Gaithersburg, MD 20877, USA. eschwartz@panaceapharma.com
Publikováno v:
Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2009 Jan 01; Vol. 14 (1), pp. 297-320. Date of Electronic Publication: 2009 Jan 01.
Autor:
Kruman II; Department of Ophthalmology, University of California, Irvine College of Medicine, Bldg. 55, Room 206, 101 The City Dr. South, Orange, CA 92868, USA. ikruman@uci.edu, Schwartz EI
Publikováno v:
Frontiers in bioscience : a journal and virtual library [Front Biosci] 2008 Jan 01; Vol. 13, pp. 2504-15. Date of Electronic Publication: 2008 Jan 01.
Autor:
Schwartz EI; Department of Pathology and Oncology, Georgetown University Medical Center, Washington, DC, USA., Smilenov LB, Price MA, Osredkar T, Baker RA, Ghosh S, Shi FD, Vollmer TL, Lencinas A, Stearns DM, Gorospe M, Kruman II
Publikováno v:
Cell cycle (Georgetown, Tex.) [Cell Cycle] 2007 Feb 01; Vol. 6 (3), pp. 318-29. Date of Electronic Publication: 2007 Feb 27.
Autor:
Pchelina SN; Saint-Petersburg Pavlov State Medical University, St. Petersburg, Russia; Petersburg Nuclear Physics Institute, St. Petersburg, Russia. sopchelina@hotmail.com, Sirotkina OV, Taraskina AE, Vavilova TV, Shwarzman AL, Schwartz EI
Publikováno v:
Thrombosis research [Thromb Res] 2005; Vol. 115 (3), pp. 199-203.
Autor:
Schwartz EI; Laboratory of Molecular Growth Regulation, NICHD, NIH, Bethesda, MD 20892-2753, USA., Intine RV, Maraia RJ
Publikováno v:
Molecular and cellular biology [Mol Cell Biol] 2004 Nov; Vol. 24 (21), pp. 9580-91.
Autor:
Demidova DV; Konstantinov Institute of Nuclear Physics, Russian Academy of Sciences, St. Petersburg State Medical University, St. Petersburg, Russia., Sirotkina OV, Kudinov SV, Schwartz EI
Publikováno v:
Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2002 Nov-Dec; Vol. 387, pp. 335-7.